Karuna switches CEOs ahead of FDA filing for schizophrenia drug

Karuna Therapeutics said former Allergan executive Bill Meury will replace its current CEO Steve Paul, a major executive shift that comes as the company prepares to seek approval of its closely watched schizophrenia medicine.